background

Media Centre

image

CURA Healthcare Launches illumina 360°
World’s First-Ever Robotic, 360° Breast Thermography System

  • CURA removes barriers to early detection & early age breast screening with illumina 360°.
  • No Pain, No Radiation, No Touch, No Breast Exposure, Non-invasive solution for all women above 18.
  • Earlier detection of breast anomalies – years ahead of current methods.
  • Designed, Developed and Made in India with support from Govt. of India.

CURA Healthcare announced today the launch of world’s first, robot-assisted digital 360 degree breast thermography device, an early breast cancer warning system for all age groups. CURA’s illumina 360° can detect breast anomalies several years ahead of prevalent breast cancer screening methods without causing pain due to compression, without non-ionizing radiation and without human touch. illumina 360° is designed, developed and manufactured in India with the support of BIRAC, Department of Biotechnology, Government of India.

“With illumina 360°, we believe we have removed most of the barriers to early breast screening – Pain, discomfort, radiation safety, and breast exposure. illumina 360° detects disease years earlier than today’s conventional screening modalities and when it is addressable without invasive and painful procedures. We believe, our illumina can be a big game changer in breast healthcare and with it mass breast screening from early ages can be a reality now in India”,” said M Bala, President and CEO of CURA Healthcare. “illumina 360° is co-created by women, leading healthcare providers and our experienced engineers to disrupt and transform the way breast screening and monitoring is done today. It represents CURA’s commitment to a ”Aarogya Bharath” through friendly, affordable and accessible technology solutions.” He added.

Breast Cancer Fact Sheet

Read Here

“We at BIRAC are here to stimulate, foster and enhance bio-tech innovation that can bridge existing healthcare gaps and improve lives of 1.3 Billion Indians. This is a critical mandate of Government of India. We are pleased to announce the birth of one such innovation - CURA’s illumina 360°, to bridge one of the biggest gaps in country – addressing the biggest killer disease of the country – Breast Cancer. We are proud to have been part of innovating this disruptive innovation” said Dr Renu Swaroop, Managing Director, Bio-technology Industry Research Assistance Council (BIRAC), Department of Bio-Technology, Government of India.

Today, India is staring at a breast cancer epidemic and breast screening is non-existent in India. 1 in 28 women get breast cancer and 1 in 2 die due to late detection, making survival one of the lowest in the world. Early detection programs in developed countries have shown that early screening can help reverse the trends. In USA, 90% of the breast cancer patients lead a long, healthy life due to early detection and early intervention. Studies reports that only about 12% of women diagnose breast cancer and over 70% presenting in late stages when it is fatal and treatment is not efficient While lack of awareness is a major reason, those who are aware also opt out of exams due to pain and discomfort. In India, breast cancer is increasingly prevalent among the young and by over a decade. Mammography is prescribed for above 45 years age groups only and hence is not available to a large 285 million population of younger women.

illumina 360° helps in identifying breast anomalies years ahead of current screening methods: The breast is a highly complex and one of the most difficult to image human organ as it varies in symmetry, density, size and morphology. Breast tissue is unique due to the mechanism of the mammary vessels, fatty tissue and skin temperatures. Substantial changes could occur to this organ during hormonal changes and different stages of life. Measurement and studying of breast skin (skin is the largest organ of the body with maximum blood circulation- about 25%) temperature and its response to hot and cold challenges in a controlled environment plays an important role in early detection of breast anomalies. illumina 360° can provide truly early insight into breast care through identification of early breast tissue changes. illumina images allow doctors to differentiate between normal and abnormal breast tissues that may develop or be caused by cysts, estrogen dominance, or fibrous tissue and potentially cancerous tissues. Most cancerous tissues require greater degree of metabolic activity and vascular/blood circulation and hence will emit an increased regional temperature. The advanced ultra-sensitive infrared camera of illumina 360° aided by an advanced robot can sense these variations through varying temperature patterns and help detect tissue changes over time. The extreme sensitivity and 360 degree coverage together with advanced digital processing can help detect the earliest thermal signs suggesting pre-cancerous stage of breast tissues or the presence of a tumor that is not yet large enough to be detectable by physical examinations, and structural imaging tools. illumina 360° provides early warning signs on breast cancer just how satellite images provide early warning signs of storms and hurricanes.

A traditional mammography system can detect breast cancer only when it reaches a cluster of 4 billion cells or the size of a grape or 1 CM size. illumina 360° produces these early warning signs at over 97% accuracy without compressing the breast, radiation and any discomfort to the patient making it very attractive for women of all age groups. illumina 360° can be used for unlimited, repeated exams as it does not emit radiation and is safe. Breast thermography is approved by FDA as an adjunct screening method to current standard of mammography. 


“illumina 360° ushers in a new age in breast care. illumina 360° is like a thermometer for the breast health assessment. An exam conducted as comfortable as an early thermometer test during fever. The high sensitivity camera of illumina 360° can detect the minutest heat changes in the breast to indicate the presence of anomalies at cellular levels. A mammography or ultrasound imaging can re-confirm its findings and together, it can be a life saver for all our women as the detection takes place years in advance and preventive measures can be taken.” Said Dr Sandeep Jaipurkar, Radiologist at Vijaya Health Centre and Breast Clinic, Chennai. Dr Sandeep Jaipurkar was one of the key partners in development of CURA’s illumina 360° and principal clinical partner for over 5 years with 5000 case studies.

“Many of my patients tell me that mammography is painful experience. illumina 360° can attract all those women who found the pain, radiation risk, touch and breast exposure a major deterrent in opting for the screening exam.” Said Prof. Kalpana, Radiologist, Madras Medical College and Rajiv Gandhi General Hospital who acted as a key partner in clinical investigations using CURA’s illumina 360°.

“No woman should miss out on the potentially life-saving benefits of regular breast screening out of pain, fear, anxiety of discomfort. illumina 360° designed with empathy after years of observation and studies of how breast screening is done today. It humanizes the mammography experience by increasing comfort and reducing patient anxiety just as in a spa. With illumina’s capability to provide 360 view of early breast tissue changes and intelligent analysis, we believe breast cancer cannot hide any more. The system's potential to help increase the number of annual screening exams is a critical advancement in women's healthcare.” said N Kannan, Head, New Product Development at CURA Healthcare. 


illumina 360° IS HIGHLY BENEFICIAL IN RADIATION FREE TREATMENT MONITORING: illumina 360° with its radiation free imaging can be used for unlimited repeat exams to monitor the effectiveness of treatment procedures. Its findings at the early stages can change the approach to treatment or alter the course or confirm how well the treatment is working. With illumina 360° now doctors can protect patient from high radiation as well as high costs per exam. Today, patients are subjected to a PET/CT exam, for monitoring of treatment, which emit radiation levels of 25 mSv equivalent to 8 years of natural background radiation.

About CURA Healthcare
CURA means Care. True to our name, we are dedicated to provide transformational healthcare solutions that can shape a new age of patient care through early detection and early treatment. Since our birth in 2001, we have been innovating and making advanced healthcare solutions in India that can help improve the curability of diseases. We have been enhancing reach of these solutions in the remotest parts of India to improve quality and affordability of care.

Media Contact:
Manoj V Menon, Commistry.- +91 9845199852. manoj@commistry.com 

Ve Ve Prabhu, Accolade PR. +91 99406 36961 accolade.publicrelations@gmail.com 

© © Copyright 2017. Cura Healthcare.